AI-generated summary
The authors studied 20 patients with temporomandibular disorders in a double-blind pilot trial comparing real and placebo 830 nm laser treatment over three sessions. They report pain improvement only in the myogenous group with real laser, and some range-of-motion gains in the arthrogenous group, but no significant difference between real and placebo groups overall.
- Participants
- 20
- Who or what was studied
- Patients with temporomandibular disorders, divided into myogenous and arthrogenous pain groups
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The authors describe this as a pilot study with a small sample, and the repeated ANOVA found no significant differences between real and placebo groups.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Pilot study, Visual analogue scale, Low-level laser therapy, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.